ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy, today announced that Company Management will be participating in the investor conferences listed below.
The Rodman & Renshaw 20th Annual Global Investment Conference taking place in New York September 4-6, 2018. ObsEva will be presenting on Wednesday September 5, 2018, at 5:05 p.m. Eastern Time.
The Baird 2018 Global Healthcare Conference taking place in New York on September 5-6, 2018. ObsEva will be presenting on Thursday September 6, 2018, at 10:50 a.m. Eastern Time.
BioCentury’s 25th Annual NewsMakers in the Biotech Industry Conference taking place in New York on Friday September 7, 2018. ObsEva will be presenting on Friday September 7, 2018 at 11:30 a.m. Eastern Time.
Investora 6th Swiss Small and Mid-Cap Conference taking place in Zürich on September 26-27, 2018. ObsEva will be presenting on Thursday September 27, 2018, at 4.15 p.m. Central Eastern Summer Time.
Rodman & Renshaw and Baird presentation webcasts will be available in the “Investors” section of ObsEva’s website www.ObsEva.com.